GSA Capital Partners’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $820K | Buy |
+61,455
| New | +$820K | 0.06% | 582 |
|
|
2025
Q1 | – | Sell |
-11,158
| Closed | -$177K | – | 1879 |
|
|
2024
Q4 | $177K | Buy |
+11,158
| New | +$177K | 0.01% | 1441 |
|
|
2024
Q2 | – | Sell |
-8,538
| Closed | -$565K | – | 1855 |
|
|
2024
Q1 | $565K | Buy |
8,538
+1,736
| +26% | +$115K | 0.04% | 801 |
|
|
2023
Q4 | $270K | Sell |
6,802
-10,359
| -60% | -$411K | 0.02% | 1170 |
|
|
2023
Q3 | $547K | Buy |
+17,161
| New | +$547K | 0.05% | 736 |
|
|
2023
Q2 | – | Sell |
-18,324
| Closed | -$782K | – | 1743 |
|
|
2023
Q1 | $782K | Buy |
18,324
+10,151
| +124% | +$433K | 0.08% | 454 |
|
|
2022
Q4 | $392K | Buy |
+8,173
| New | +$392K | 0.05% | 755 |
|